- Continue Shopping
- Your Cart is Empty
Hexoskin in Boston/Cambridge for the 9th Annual Digital Implementation Summit 2026 at Pfizer
Hexoskin is proud to sponsor the 9th Annual Digital Implementation Summit this November 3rd hosted at Pfizer in Cambridge, MA.
At Hexoskin, we believe digital measures deliver value when clinical protocols are designed with the patient in mind and with a great training and support of clinical sites. Here’s what we offer...
View full article →Hexoskin in South San Francisco for the 3rd Annual Clinical Trial Innovation Summit 2026 at Genentech
Hexoskin is proud to sponsor the 3rd Annual Clinical Trial Innovation Summit this October 13th hosted at Genentech in South San Francisco.
Over the past 10 years, the research community has invested heavily in AI, digital biomarkers, digital twins, decentralized trials, tokenization, and digital health technologies. We've learned when these technologies are useful and valuable, and when they're not. Now it's time to make them work at scale, across sites, populations, in ways that patients and sponsors both feel.
The gap between a successful pilot and routine, patient-centered practice is called the “valley of adoption” and is the focus of this year's summit. More than 25 speakers and over 200 senior leaders in clinical research, operations, and trial design will look at where innovation is delivering measurable value, where implementation still stalls, and how good approaches can be scaled responsibly.
What crossing the valley looks like from our side
At Hexoskin, we’ve learned that adoption depends less on what a technology can measure and more on how we operationalize it in a successful trial. Here’s what we bring to sponsors working to close that gap:
-
A dedicated team that supports your study from protocol design to biostatistical analysis. More than sensors and a software platform for managing data collection across sites and cohorts of patients, our team support you through all the steps of a trial, include site training, tech support, and logistics.
-
Only FDA-cleared wearable for both cardiac and respiratory markers. The Hexoskin Smart Shirt records 3-lead ECG, dual-channel respiratory inductance plethysmography (RIP), and 3-axis accelerometry, all from one comfortable garment. Respiratory patterns are rarely captured continuously outside the lab, and Hexoskin has pioneered their use for many disease categories.
- 112 digital biomarkers from a single device. These range from heart rate variability and breathing patterns to gait, sleep, and physical activity. Sponsors can choose the endpoints that matter for their program without adding devices, or burden, for participants.
- Endpoints and early signals across therapeutic areas. Hexoskin data supports research in neurology, rare diseases, and respiratory disease, among other areas. In rare disease especially, a small population means every data point and patient reported outcome is especially valuable.
- A growing body of evidence. Hexoskin has been used in more than 350 scientific publications. You can browse the literature by field in our online paper database.
Contact our team for more information.
Hexoskin in Basel for the Digital Biomarkers in Clinical Trials & Clinical Trial Innovation Summits June 23-24
Hexoskin is proud to sponsor this week the 9th Digital Biomarkers in Clinical Trials Summit and the 6th Clinical Trial Innovation Summit, hosted in partnership with Roche in Basel, Switzerland.
View full article →Hexoskin in San Diego for BIO 2026
Hexoskin will be in San Diego this June 22-24 for the BIO 2026 International Convention, the world's largest and most comprehensive event for the global biotechnology and life sciences industry. Hosted by the Biotechnology Innovation Organization, the gathering brings together over 20,000 leaders from startups, Pharma companies, academia, and government agencies
View full article →Hexoskin to Present at the HITLAB Innovation Summit 2025
Hexoskin's CEO Pierre-Alexandre Fournier is going to present our latest work in AI and digital biomarker development for clinical trials at the HITLAB Innovators Summit 2025 this December 2-4 in New York City.
Hexoskin Medical System Receives FDA 510(k) Clearance for Long-Term ECG and Respiratory Monitoring
The Hexoskin Medical System (HMS) is now an FDA-cleared, medical-grade smart shirt for continuous, long-term ECG, respiratory, and activity monitoring. It’s a premier remote monitoring solution for cardiopulmonary chronic conditions (COPD, Afib) and complements the validated AI-based digital biomarker platform for clinical trials in cardiovascular, respiratory, and rare diseases.
View full article →Hexoskin wins contract to bring Astroskin sensors to the Moon
Montréal, November 26th, 2024
The Canadian Space Agency (CSA) has announced that it has awarded a contract to Hexoskin (Carré Technologies Inc.), a company based in Montreal, to develop and adapt the Astroskin Bio-Monitor crew physiological monitoring system for Gateway, a space station that will orbit the Moon.
The first two elements of Gateway – the Power and Propulsion Element (PPE) and the Habitation and Logistics Outpost (HALO) – are set to launch together in 2027.
The Astroskin Bio-Monitor has been in operation on the International Space Station (ISS) since January 2019, when it was commissioned by Canadian astronaut David Saint-Jacques. It is currently used in four clinical trials in space focused on studying the cardiorespiratory system and the accelerated aging effect of microgravity on human physiology.
Astroskin wearable sensors are sent to space on a regular basis, with 20 space payloads delivered to ISS so far, and a first suborbital flight completed in November 2023 with American astronaut Kellie Gerardi on Virgin Galactic’s mission 5.
More than 20 astronauts have used Astroskin wearable sensors for clinical research in microgravity, including astronauts from the USA, Canada, Japan, UAE, and Italy. (Photo credits: CSA, ESA, NASA, JAXA, Axiom/Mark Pathy, UAE Space Agency)
Astroskin wearable health sensors are also used by a large number of medical researchers around the world to study a wide number of health conditions, from hypertension to sleep quality, in clinical trials, and for defense and aerospace applications.
About Hexoskin, Space Medicine, and Clinical Research
Hexoskin has been involved in space medicine since its first contract with CSA in 2011. The investment from CSA in space medicine research has been a major driver of growth in the early development of the company, during the development of the Hexoskin and Astroskin wearable sensor platforms. Hexoskin has supported hundreds of clinical research projects since, leading to over 250 peer-reviewed scientific publications, patents, and novel AI software for clinical applications, with a focus on cardiac and respiratory diseases. Hexoskin participated in the first cohort of the ASU/Mayo Clinic Medtech accelerator in 2019.
More info on the Gateway contract awarded to Hexoskin:
https://www.nasa.gov/mission/gateway/
More info on Astroskin:
https://www.hexoskin.com/astroskin
Hexoskin @ HITLAB New York City Health Innovation Week
This week Hexoskin was participating in HITLAB's New York City Health Innovation Week in Manhattan. The event was attended by dozens of startups and large life science companies such as Merck, Novo Nordisk, and Sanofi.
To learn more about Hexoskin's involvement in pharma trials and clinical research, please write us at: contact@hexoskin.com
OneView Clinical Research Software Overview
Hexoskin OneView is a clinical software platform that allows health professionals and researchers to design their own protocols and easily monitor their projects and studies.
Our community uses it to collect data from patients in occupational wellness programs, rehabilitation programs, and clinical trials.
Participants can use an app to follow a program's calendar, complete questionnaires and enter all kinds of data you need to track their progress and monitor the performance of your project.
On top of that, you'll find it easy to:
-
manage cohorts and calendars
-
monitor data quality and compliance
-
use study templates, standardized questionnaires and health reports
-
easily clone protocols to create new study arms or health programs
-
use the sizing tool to pick the right size shirt to onboard participants
-
export all data to other systems like Excel, R and SAS for biostatistics
- the tools are available for Astroskin too!
Contact our team to see how we can support your program or study and access a free trial. We offer turnkey services for a wide range of projects, from protocol planning and design, to recruitment and study support, to biostatistics and endpoints.
Hexoskin @ 2024 JP Morgan Conference
Hexoskin will be in San Francisco again this year during the 42nd Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.
We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
